»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 5qbq,#Pf
bO3GVc+S
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 ZyI$M 3{J
A1),el-^5
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© +;Cr];b3
1.Antigen presenting cell£¨APC£© ~$<UE}qp
2.Activation induced cell death£¨AICD£© $wV1*$1NM
3.Chemokine rp's
4.Major histocompatibility complex£¨MHC£© gCuAF$o
5.immunotolerance rrqQCn9
E.`6oX\L|
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© &!L:"]=+
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ <
Ek/8x
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà yNCEz/4
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ hmC*^"C>U=
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ O_;Dk W
5.±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã 4)kG-[#
SeEw.;Xw
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© ~"K,7sw!Y
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ ZmEEj-*7s
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ 9Uf j
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ Ps4 ZFX
ik.A1j9oN
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ mr:CuqJ
4J0Rvod_
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 #8XL
:I
][&9]omB
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ r'GP$0rr9!
1.Antigenic determinant CGbwm
Px
2.IgSF _S}A=hK'
3.MBL;¾¶ #,d I$gY
4.chemokine r^Zg-|gr
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ a^U~
0i@[S
6.TCR-CD3¸´ºÏÎï [ic 870_
7.FADD£¨Fas-associated protein with death domain£© v'!a\b`9
8.AIDS ' o_:^'c
9.Tumor rejection antigen ,Wbwg
10.AICD Gh.[dF?
[* ?Awf`
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ aJ") <_+
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© *z*uEcitW
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ .mLK`c6
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ jRSUp
E8
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì UcOk3{(z$q
{!t7[Ctb
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ fC,:{}
0Z[oKXm1p
VXIP0p@
רҵ¿Î ÃâÒßѧ -K9c@?
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê n!p<A.O7@
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell (bsXo
q
5. Fc¦Å receptor 6. Cytokine "j;4
k.`h
¶þ¡¢ ÎÊ´ðÌâ $YN6<5R)
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØÉ±É˰Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 -gSUjP
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ ?7<JQh)"e
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁܰÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ 79`AM
X[b
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâÐ©ÌØµãµÄÉúÎïѧÒâÒ壿 AC>`'Gx
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦ÓᣠTb3J9q+ya
+qh[N@F
_?OW0x4
JSW
^dw&
O8B\{T1
=-IbS}3
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Vx~,Uex0+
UrqRx?#
S H!
רҵ¿Î ÃâÒßѧ bbrXgQ`s+w
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê WZ.@UN,
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen &YF^j2
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin :A/d to
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test 7=;R& mqC
9. Hybridoma technic 10.Mitogen !\7!3$w'8,
11.Dentritic cell 12.Immunoproliferation nih0t^m'
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ rJGf.qJJ
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨ÄöÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ ;lHr =e7
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠ[u
cpd
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ G"h'_7
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ e
9;~P}
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ Yt;MV)
|y(Q
3kybLOG
SLa>7`<Q
As'=tIro
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ o]4*|ARPs
?8'*,bK
,U2*FZ["
רҵ¿Î ÃâÒßѧ a
AD^^l#
Ò»¡¢ Ãû´Ê½âÊÍ jIJ~QpNE
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï pH9VTM.*
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà `sn^ysp
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ 0Tx6zO
¶þ¡¢ ÎÊ´ðÌâ h`^jyoF"(
1¡¢ TÁܰÍϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ p M4 :#%V
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁܰÍϸ°ûºÍЧӦÎïÖÊ¡£ H?yK~bGQ
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆä¹²Í¬Ìص㼰ÓëÁÙ´²µÄ¹ØÏµ¡£ NPy&O